Highlighted opportunities include NANO Nuclear Energy's niche potential, Christian Dior SE's LVMH exposure, and Harrow's ...

Biotech stories typically tread a very fine line between promise and pressure. Sometimes a company that’s been a pioneer in ...

Clinical-stage biotech stocks carry significant risks, but also offer explosive upside potential. These companies are built ...

HYPE has declined 3.3% in 24 hours to $45.13 despite Hyperliquid platform recording historic $18.99 billion daily perpetuals ...

Asia-Pacific markets ended Thursday on a mixed note, with Australian stocks hitting a record high and Hong Kong equities rallying.